Your browser doesn't support javascript.
loading
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial.
Yang, Wenying; Ma, Jianhua; Hong, Tianpei; Liu, Ming; Miao, Heng; Peng, Yongde; Wang, Changjiang; Xu, Xiangjin; Yang, Tao; Nielsen, Anne M; Pan, Lili; Liu, Weihong; Zhao, Weigang.
Affiliation
  • Yang W; China-Japan Friendship Hospital, Beijing, China.
  • Ma J; Nanjing First Hospital, Nanjing, China.
  • Hong T; Peking University Third Hospital, Beijing, China.
  • Liu M; Tianjin Medical University General Hospital, Tianjin, China.
  • Miao H; Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Peng Y; Shanghai First People's Hospital, Shanghai, China.
  • Wang C; First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xu X; Fuzhou General Hospital of Nanjing Military Command, Fuzhou, China.
  • Yang T; Jiangsu Province Hospital, Jiangsu, China.
  • Nielsen AM; Medical & Science Degludec Portfolio, Novo Nordisk A/S, Søborg, Denmark.
  • Pan L; Novo Nordisk (China) Pharmaceuticals Co. Ltd, Beijing, China.
  • Liu W; Novo Nordisk (China) Pharmaceuticals Co. Ltd, Beijing, China.
  • Zhao W; Peking Union Medical College Hospital, Beijing, China.
Diabetes Obes Metab ; 21(7): 1652-1660, 2019 07.
Article in En | MEDLINE | ID: mdl-30869183

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Biphasic Insulins / Insulin Aspart / Hypoglycemic Agents / Insulin, Isophane Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Biphasic Insulins / Insulin Aspart / Hypoglycemic Agents / Insulin, Isophane Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Document type: Article Affiliation country: China Country of publication: United kingdom